Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification and Evaluation of Endogenous Markers for the Assessment of CYP3A Activity Using Metabolomics

NCT01215214 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT01215214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01215214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification and Evaluation of Endogenous Markers for the Assessment of CYP3A Activity Using Metabolomics
Lead sponsor
Seoul National University Hospital
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2010
Completion date
January 31, 2011
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy